Case Control Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Feb 14, 2020; 26(6): 627-644
Published online Feb 14, 2020. doi: 10.3748/wjg.v26.i6.627
Table 1 Correlation of miR-19a-3p and Forkhead box F2 with pathological data of colorectal cancer patients
FactorsnRelative expression of miR-19a-3ptP valueRelative expression of FOXF2tP value
Sex
Male (n = 32)1.08 ± 0.149.600< 0.0010.41 ± 0.139.686< 0.001
Female (n = 30)1.41 ± 0.130.73 ± 0.13
Age
< 57 years-old (n = 24)1.03 ± 0.139.140< 0.0010.36 ± 0.1110.080< 0.001
≥ 57 years-old (n = 38)1.37 ± 0.150.70 ± 0.14
TNM stage
I, II (n = 35)1.1 ± 0.149.203< 0.0010.43 ± 0.139.910< 0.001
III, IV (n = 27)1.42 ± 0.130.76 ± 0.13
Tumor size
< 3 cm (n = 30)1.06 ± 0.1310.290< 0.0010.4 ± 0.1210.370< 0.001
≥ 3 cm (n = 32)1.4 ± 0.130.73 ± 0.13
Lymph node metastasis
Yes (n = 42)1.12 ± 0.1410.780< 0.0010.46 ± 0.149.615< 0.001
No (n = 20)1.49 ± 0.090.81 ± 0.12
Differentiation
Low (n = 27)1.39 ± 0.1410.290< 0.0010.38 ± 0.1210.080< 0.001
Medium and high (n = 35)1.05 ± 0.120.72 ± 0.14